Anti-Diabetic Effect of Moringa Leaf in Insulin-Resistant and Diabetic Rats

Moringa leaf is one of the most studied natural aids for blood-sugar control. This study tested aqueous Moringa oleifera leaf extract across two different diabetes models to probe how it works.

Insulin resistance was induced with a high-fructose diet, and type-1 diabetes with a streptozotocin (STZ) injection. Moringa leaf extract was given at 200 mg/kg for 60 days, and the team tracked body weight, plasma glucose, insulin, lipid profile, the HOMA insulin-resistance index, and an oral glucose tolerance test.

What the study examined

Moringa leaf’s effect in both insulin-resistant and type-1 diabetic models.
A comprehensive metabolic panel: glucose, insulin, lipids, HOMA and glucose tolerance.
A sustained 60-day supplementation period.

Why it matters for MORIFA: Diabetes and metabolic health is a huge functional-food market. Mechanistic evidence across multiple diabetes models reinforces moringa leaf powder — our flagship — as an evidence-backed ingredient.

Caveat: an animal study; this is research information, not medical advice.

Summary of: “Antidiabetic of Moringa in Fructose Fed Insulin Resistant and STZ Induced Diabetic Wistar Rats.” Summarised by MORIFA; full paper via the PDF link above.

This page summarises independent, third-party research for educational purposes. MORIFA does not claim authorship of the original study; please consult the original publication via the link above.